Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Rev Esp Cardiol. 1997 Jul;50(7):459-63.

[Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments in favor].

[Article in Spanish]

Author information

  • 1Centro Cardiovascular, Hospital OLV, Aalst, Bélgica.

Abstract

The conventional antiarrhythmic treatment of ventricular arrhythmias causing sudden death is the implantable cardioverter defibrillator. Any drug, intervention or device designed to prevent sudden death should be compared in the future in a prospective and randomized way with the implantable cardioverter defibrillator as the standard treatment. The MADIT strategy should be considered as the conventional treatment of the patients with sustained ventricular arrhythmias and of the patients with nonsustained ventricular arrhythmias and depressed left ventricular ejection fraction.

PMID:
9304171
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ediciones Doyma, S.L.
    Loading ...
    Write to the Help Desk